ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bradding, P.
Right arrow Articles by Cruse, G.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Bradding, P.
Right arrow Articles by Cruse, G.
Eur Respir J 2005; 26:745-746
Copyright ©ERS Journals Ltd 2005

From the authors

P. Bradding and G. Cruse

Dept of Infection, Immunity and Inflammation, University of Leicester, Leicester, UK

We are writing in response to the letter to the European Respiratory Journal by S. Hart and I. Dransfield regarding our recent paper 1. We thank them for bringing to our attention that the centrifugation of our immunoglobulin (Ig)-E preparation at 14,000xg for 20 min might be insufficient to remove IgE aggregates or multimers. We are, however, confident that the human myeloma IgE that we used in our experiments is free from such complexes (a belief that is shared by the manufacturer Calbiochem).

Purified Ig preparations often contain immune aggregates. This has been demonstrated in several rodent studies 24. These studies have also demonstrated that the efficacy of such IgE aggregates at initiating a response in mast cells is very poor compared with that of monomeric IgE.

These studies used high-performance liquid chromatography 2, 3, or size-exclusion chromatography 4 to ensure that their IgE preparations were truly monomeric, and recorded an array of responses with the monomeric forms. There are many recent studies which agree that monomeric IgE induces an array of responses in mast cells 58. In our study we used IgE that was purified from the plasma of a myeloma patient. These preparations, therefore, are paraproteins that, as evidenced in IgE multiple myeloma, do not readily form dimers such as IgA or pentamers such as IgM, in the absence of a soluble antigen. The preparations have been assayed by the manufacturer using immunoelectrophoresis and produced a single arc, which further suggests a lack of aggregates or multimers. Any affinity for binding epitopes on the IgE molecules themselves would be very low. However, if there are intermolecular interactions with the IgE molecules at the receptor sites on the mast cell surface, as has been suggested in a recent mathematical model 9, this would not disprove the theory that monomeric IgE is an important activator of mast cell secretion, as the cross-linking of IgE by such interactions would occur in vivo at the same concentrations (the concentrations we used were experienced in vivo).

Therefore, we are not mimicking allergen exposure, but instead representing the physiological response to increased serum immunoglobulin E.

REFERENCES

  1. Cruse G, Kaur D, Yang W, Duffy SM, Brightling CE, Bradding P. Activation of human lung mast cells by monomeric immunoglobulin E. Eur Respir J 2005;25:858–863.[Abstract/Free Full Text]
  2. Kalesnikoff J, Huber M, Lam V, et al. Monomeric IgE stimulates signalling pathways in mast cells that lead to cytokine production and cell survival. Immunity 2001;14:801–811.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  3. Lam V, Kalesnikoff J, Lee CW, et al. IgE alone stimulates mast cell adhesion to fibronectin via pathways similar to those used by IgE + antigen but distinct from those used by steel factor. Blood 2003;102:1405–1413.[Abstract/Free Full Text]
  4. Pandey V, Mihara S, Fensome-Green A, Bolsover S, Cockcroft S. Monomeric IgE stimulates NFAT translocation into the nucleus, a rise in cytosol Ca2+, degranulation, and membrane ruffling in the cultured rat basophilic leukemia-2H3 mast cell line. J Immunol 2004;172:4048–4058.[Abstract/Free Full Text]
  5. Nunomura S, Gon Y, Yoshimaru T, et al. Role of the Fc (varepsilon) RI (ß)-chain ITAM as a signal regulator for mast cell activation with monomeric IgE. Int Immunol 2005;[Epub ahead of print]:
  6. Kitaura J, Eto K, Kinoshita T, et al. Regulation of highly cytokinergic IgE-induced mast cell adhesion by Src, Syk, Tec, and protein kinase C family kinases. J Immunol 2005;174:4495–4504.[Abstract/Free Full Text]
  7. Tanaka S, Mikura S, Hashimoto E, Sugimoto Y, Ichikawa A. Ca2+ influx-mediated histamine synthesis and IL-6 release in mast cells activated by monomeric IgE. Eur J Immunol 2005;35:460–468.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  8. Kitaura J, Kinoshita T, Matsumoto M, et al. IgE- and IgE+Ag-mediated mast cell migration in an autocrine/paracrine fashion. Blood 2005;105:3222–3229.[Abstract/Free Full Text]
  9. Schweitzer-Stenner R, Pecht I. Death of a dogma or enforcing the artificial: monomeric IgE binding may initiate mast cell response by inducing its receptor aggregation. J Immunol 2005;174:4461–4464.[Abstract/Free Full Text]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bradding, P.
Right arrow Articles by Cruse, G.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Bradding, P.
Right arrow Articles by Cruse, G.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS